Brief: ResShape Lifesciences Reports Year Ended December 31, 2022 Financial Results
25/04/2023 22:12
April 25 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES® REPORTS YEAR ENDED DECEMBER 31, 2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* RESHAPE LIFESCIENCES INC Q4 REVENUE $2.7 MILLION
Source text for Eikon: ID:nGNX7JKwXP
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity